About Us
About Us
We are a team of experienced radiologists and oncologists working collaboratively to help oncology practices configure imaging solutions for clinical trials.
Our Team
Sree Harsha Tirumani MD
Dr. Tirumani is a Board-Certified Radiologist accredited by the American Board of Radiology. He completed fellowship training in abdominal and oncologic imaging at renowned North American institutions, including the Dana-Farber Cancer Institute. Dr. Tirumani brings over a decade of clinical expertise in evaluating solid tumors and hematologic malignancies utilizing ultrasound, CT, MRI, and PET/CT. He is recognized as an authority in tumor response assessment, with proficiency in RECIST 1.1, irRC, iRECIST, and lymphoma-specific response criteria. A fellow of Society of Abdominal Radiology, Dr. Tirumani has delivered numerous lectures and authored more than 200 peer-reviewed publications, including pioneering research on treatment response and complications associated with novel cancer therapies.
Dr. Tirumani is Board Certified Radiologist by the American Board of Radiology. He is fellowship trained in abdominal imaging and cancer imaging from prestigious universities in North America. He is a staff physician at a leading academic medical center with NCI designated cancer center. Dr. Tirumani has more than 10 years clinical experience in solid tumor and hematologic malignancy evaluation using US, CT, MRI and positron emission tomography-computed tomography (PET/CT). He is an expert in tumor response assessment including RECIST 1.1, irRC, iRECIST and response criteria for lymphomas. He has delivered multiple lectures and has published several articles on treatment response and complications of novel cancer therapies.
Anil Chauhan MD, MBA
Dr. Chauhan is a Professor of Radiology and a visionary leader in the integration of machine learning and quantitative diagnostics. With foundational training from MD Anderson Cancer Center, Dr. Chauhan is passionate about developing non-invasive biomarkers to revolutionize therapeutic monitoring and diagnostic precision. His leadership is marked by the successful establishment of the AI-enabled tumor metrics core and the Center for Advanced Quantitative Imaging, creating the infrastructure necessary for modern precision medicine. A Fellow of the SRU, SAR, and AIUM with over 50 peer-reviewed works, Dr. Chauhan combines deep clinical expertise in Abdominal Imaging with a strategic business lens to lead global advancements in AI-driven oncology research.
Dhruv Bansal MD, MBA
Dr. Dhruv Bansal is a medical oncologist specializing in thoracic malignancies, immunotherapy, and precision oncology. He has extensive experience in clinical trial design, and has served as PI on multiple Phase 1-3 clincal trials
Dr. Bansal’s research spans biomarker discovery, ctDNA-guided therapy, and the clinical design of immunotherapy and targeted therapy trials in non–small cell lung cancer. He has led and published multiple multi-institutional studies on immunotherapy outcomes, ctDNA dynamics, and molecular correlates of response in NSCLC, including work in JAMA Network Open and Journal of Thoracic Oncology.
Previously, Dr. Bansal directed Precision and Thoracic Oncology at Saint Luke’s Cancer Institute and served on the ASCO CancerLinQ Physician Advisory Committee and the Alliance Respiratory Committee. He has been recognized with national awards from the Association of Cancer Care Centers for innovation in precision medicine workflow integration.
Dr. Bansal earned his MD in India, completed his internal medicine residency at the University of New Mexico, and his hematology-oncology fellowship and MBA at Washington University in St. Louis.